Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Chronic Lymphocytic Leukemia (CLL) MRD Panel By Flowcytometry is 10 days.

What are the prerequisites for the test Chronic Lymphocytic Leukemia (CLL) MRD Panel By Flowcytometry

  • Specimen Type: Peripheral blood collected in EDTA tube
  • Specimen Volume: 5 mL
  • Specimen Stability: Stable at room temperature for up to 24 hours
  • Specimen Storage: Refrigerate at 2-8°C
  • Specimen Transport: Ship at room temperature
  • Turnaround Time: 5-7 days
  • Methodology: Flow cytometry
  • Preparation: No fasting required
  • Special Instructions: Please provide clinical history and any relevant information

What are the measure values for the test Chronic Lymphocytic Leukemia (CLL) MRD Panel By Flowcytometry

Measure Value
CD5+CD19+CD20+CD23+ Positive
CD5+CD19+CD20+CD23- Positive
CD5+CD19+CD20-CD23+ Positive
CD5+CD19-CD20+CD23+ Positive
CD5-CD19+CD20+CD23+ Positive
CD5+CD19+CD20-CD23- Positive
CD5+CD19-CD20+CD23- Positive
CD5-CD19+CD20+CD23- Positive

What does this test Chronic Lymphocytic Leukemia (CLL) MRD Panel By Flowcytometry identify?

  • This test identifies minimal residual disease (MRD) in patients with Chronic Lymphocytic Leukemia (CLL) using flow cytometry.
  • MRD refers to the small number of cancer cells that may remain in the body during or after treatment.
  • Flow cytometry is a technique used to analyze the characteristics of cells, such as size, shape, and protein expression, by passing them through a laser beam.
  • By analyzing the cells in the blood or bone marrow sample, this test can determine the presence of residual CLL cells at levels below the detection limit of other methods.

Why is this test Chronic Lymphocytic Leukemia (CLL) MRD Panel By Flowcytometry taken?

Chronic Lymphocytic Leukemia (CLL) MRD Panel By Flowcytometry

Chronic Lymphocytic Leukemia (CLL) MRD Panel By Flowcytometry is a test that is taken to monitor the minimal residual disease (MRD) in patients with CLL. MRD refers to the small number of leukemia cells that may remain in the body after treatment, even when the patient is in remission. Monitoring MRD levels can help doctors determine the effectiveness of treatment and predict the likelihood of disease relapse.

This test is particularly important for patients with CLL because the disease tends to be slow-growing and may not cause symptoms for many years. By measuring MRD levels, doctors can assess the risk of disease progression and tailor treatment plans accordingly. The test is typically performed at regular intervals during and after treatment to track changes in MRD levels over time.

No FAQs available.

Customer Google Rating